SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-032821
Filing Date
2021-12-30
Accepted
2021-12-30 16:05:44
Documents
15
Period of Report
2021-12-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44003
2 ex10-1.htm EX-10.1 14291
3 ex10-1_001.jpg GRAPHIC 5262
  Complete submission text file 0001493152-21-032821.txt   285865

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adxs-20211230.xsd EX-101.SCH 3754
5 XBRL DEFINITION FILE adxs-20211230_def.xml EX-101.DEF 27291
6 XBRL LABEL FILE adxs-20211230_lab.xml EX-101.LAB 37547
7 XBRL PRESENTATION FILE adxs-20211230_pre.xml EX-101.PRE 25910
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5275
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 211532900
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences